Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal Timing for Expander to Implant Exchange After Postmastectomy Radiation Therapy.

Annals of plastic surgery·2026
Same author

In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis.

EClinicalMedicine·2026
Same author

Accuracy of Histology and Malignancy Grade Between Preoperative Biopsy and Surgical Specimens in Primary Retroperitoneal Sarcoma. A Study From the Prospective Retroperitoneal Sarcoma Registry (RESAR).

Annals of surgery·2025
Same author

ASO Practice Guidelines Series: Soft Tissue Sarcoma of the Extremities and Superficial Trunk.

Annals of surgical oncology·2025
Same author

Surgical Management of Retroperitoneal Liposarcoma: Opportunities for Multimodality Treatment, Including Systemic Therapy.

Cancer medicine·2025

Related Experiment Video

Updated: Sep 1, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

759

Retroperitoneal Sarcomas: Histology Is Everything.

Michael K Turgeon1, Kenneth Cardona2

  • 1Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, 1365 Clifton Road, NE, Building B, Suite 4100, Office 4201, Atlanta, GA 30322, USA.

The Surgical Clinics of North America
|August 11, 2022
PubMed
Summary

Retroperitoneal sarcomas (RPS) management is evolving with precision medicine. Recent updates emphasize histology-specific approaches for better treatment and surveillance of these rare soft tissue tumors.

Keywords:
Active surveillanceHistiotypeMultimodality therapyRetroperitoneal sarcomaSurgery

More Related Videos

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K
Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
06:36

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Published on: May 1, 2019

7.1K

Related Experiment Videos

Last Updated: Sep 1, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

759
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.7K
Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue
06:36

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Published on: May 1, 2019

7.1K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Retroperitoneal sarcomas (RPS) are rare soft tissue sarcomas with diverse subtypes.
  • Each subtype exhibits unique biology, clinical behavior, and requires tailored management.
  • Traditional approaches are being refined by precision medicine insights.

Purpose of the Study:

  • To summarize recent advancements in the management of retroperitoneal sarcomas.
  • To highlight the importance of a histology-specific approach in RPS therapy.
  • To provide an updated overview of treatment strategies, recurrence risks, and surveillance.

Main Methods:

  • Review of current literature and recent clinical updates on RPS management.
  • Analysis of histology-specific tumor biology and its impact on treatment.
  • Integration of precision medicine principles into therapeutic decision-making.

Main Results:

  • A nuanced, histology-specific approach to RPS therapy is increasingly adopted.
  • Treatment strategies now integrate surgery, neoadjuvant radiation, and/or chemotherapy based on subtype.
  • Understanding tumor biology and location refines recurrence risk assessment and surveillance plans.

Conclusions:

  • Precision medicine necessitates tailored management strategies for distinct RPS subtypes.
  • Histology-specific therapeutic decisions improve outcomes for patients with retroperitoneal sarcomas.
  • Ongoing research continues to refine the optimal care pathways for RPS.